Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

Merck & Co. Inc. closed 41.34% below its 52-week high of $134.63, which the company achieved on June 25th.

Parents and Guardians has been urged to increase the scope of proper parenting to their children in order to enable them to ...

Fintel reports that on April 22, 2025, Cantor Fitzgerald initiated coverage of Merck (NYSE:MRK) with a Neutral recommendation ...

Merck MRK will report its first-quarter 2024 earnings on April 24, before market open. The Zacks Consensus Estimate for first ...